enter passkey to continue
incorrect passkey
Precision medicine at altitude
Colorado's healthcare ecosystem is built on innovation. From the Anschutz Medical Campus to the growing Front Range biotech corridor, the state is positioned to lead the integration of genomic medicine into value-based care delivery.
A convergence of world-class pediatric medicine, academic research power, and a life sciences ecosystem primed for genomic integration.
Ranked among the nation's top pediatric centers, with a Level IV NICU where rapid genomic sequencing delivers diagnostic yields of 34–59%. Every critically ill neonate deserves a molecular answer within their admission.
One of the largest academic health science campuses in the nation, housing the University of Colorado School of Medicine. A research and clinical hub generating the evidence base that CarePathways translate into practice.
Colorado's life sciences sector is growing rapidly along the Front Range, attracting genomics companies, diagnostic laboratories, and bioinformatics talent that form the operational backbone of precision medicine delivery.
With 64 counties classified as rural or frontier, Colorado's geography creates a significant access gap for specialty genomic services. Telegenetics and structured CarePathways can bridge this divide systematically.
Evidence-based, bundled care episodes designed for Colorado's patient population, provider landscape, and payer environment. Each pathway turns a diagnostic question into a measurable, cost-effective care episode.
Rapid whole-genome and exome sequencing for critically ill neonates and children at Children's Hospital Colorado. Diagnosis within the admission eliminates the diagnostic odyssey before it begins and reduces NICU length of stay by up to 25%.
Structured exome and genome sequencing for undiagnosed patients cycling through Colorado's health system. Targeting the 5–7 year diagnostic odyssey that generates $50,000–$500,000+ in unnecessary care per patient, with telegenetics bridging access for rural communities.
Colorado's altitude creates a unique clinical context for pulmonary genetic conditions. Primary ciliary dyskinesia, hereditary pulmonary arterial hypertension, and pulmonary fibrosis present with distinct phenotypic profiles at elevation, making early molecular diagnosis critical.
Comprehensive genomic profiling integrated into Colorado's cancer care networks. Tumor-normal sequencing, germline risk assessment, and pharmacogenomic optimization ensure that every oncology patient receives targeted, evidence-driven therapy from the start.
Genomic medicine should not require a drive to Denver. Structured telegenetics pathways extend the reach of Colorado's academic centers to every corner of the state.
Colorado's rural and frontier communities face a compounded version of the rare disease challenge: the same diagnostic odyssey that wastes years and resources in urban settings becomes even longer when the nearest geneticist is a four-hour drive away.
CarePathways solve this by embedding telegenetics consultation, remote sample collection, and digital result delivery into a single structured care episode. The patient stays in their community. The expertise comes to them.